MTNB icon

Matinas BioPharma
MTNB

Overview Fund Activity

71 hedge funds and large institutions have $57.1M invested in Matinas BioPharma in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 9 closing their positions.

Holders
71
Holders Change
+10
Holders Change %
+16.39%
% of All Funds
1.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
11
Reduced
15
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$1.66M
2
PFMOSF
2
Philadelphia Financial Management of San Francisco
California
$1.01M
3
SIG
3
Sargent Investment Group
Maryland
$1.94M
4
ECM
4
ExodusPoint Capital Management
New York
$854K
5
Millennium Management
5
Millennium Management
New York
$597K

Top Sellers

1
VC
1
Vivo Capital
California
$8.77M
2
Two Sigma Investments
2
Two Sigma Investments
New York
$130K
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$790K
4
RJFSA
4
Raymond James Financial Services Advisors
Florida
$0
5
DA
5
DCF Advisers
Connecticut
$415K
Name Holding Trade Value Shares
Change 		Shares
Change %
Ameriprise
76
Ameriprise
Minnesota
– -$8K -219 Closed
LA
77
Legacy Advisors
Pennsylvania
– -$8K -200 Closed
JC
78
JBF Capital
Colorado
– -$5K -135 Closed
CAL
79
Capital Analysts LLC
Pennsylvania
– -$1K -25 Closed
1 2 3
4